Obesity and anemia in the diagnosis of breast cancer
Keywords:Obesity, breast cancer, anemia
Obesity (Ob) and anemia are common pathologies associated with a poor prognosis during breast cancer (BC) treatment. However, there are not enough data on the presence of these pathologies at the time of diagnosis, resulting in a late medical-nutritional intervention, which entails a wide variety of complications that affect the quality of life and prognosis of patients. This study analyzed the presence of Ob and anemia retrospectively in 715 women who were diagnosed with BC. The mean value for the body mass index (BMI) was 29.12kg/m2 while the highest prevalence in the analysis by age groups was for overweight and Ob; age and BMI showed a positive correlation. 15.43% of the women presented anemia and only a negative correlation trend was observed between hemoglobin values and BMI. The results showed that 7 out of 10 women are overweight and 1 in 6 is anemic, the highest prevalence of anemia was in the overweight group.
García-Estévez L, Cortés J, Pérez S, Calvo I, Gallegos I, Moreno-Bueno G. Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status. Front Oncol. 2021;11:705911.
Cárdenas-Sánchez J, Erazo-Valle-Solís AA, Arce-Salinas C, Bargalló-Rocha E, Bautista Piña V, Cervantes-Sánchez G, et al. Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. Octava revisión. Colima 2019. Gac Mex Oncol. 2019;18(3):141-231.
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention: Breast Cancer, Inflammation, and Obesity. CA Cancer J Clin. 2017;67(5):378-97.
Laudisio D, Muscogiuri G, Barrea L, Savastano S, Colao A. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. Eur J Obstet Gynecol Reprod Biol. 2018;230:217-21.
Engin A. Obesity-associated Breast Cancer: Analysis of risk factors. Adv Exp Med Biol. 2017;960:571-606.
Fortner RT, Katzke V, Kühn T, Kaaks R. Obesity and Breast Cancer. Recent Results Cancer Res, 2016;208:43-65.
Park JW, Han K, Shin DW, Yeo Y, Chang JW, Yoo JE, et al. Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women. Breast Cancer Res Treat. 2021;185(2):495-506.
Iwase T, Wang X, Shrimanker TV, Kolonin MG, Ueno NT. Body composition and breast cancer risk and treatment: mechanisms and impact. Breast Cancer Res Treat. 2021;186(2):273-83.
Bhardwaj P, Au CC, Benito-Martin A, Ladumor H, Oshchepkova S, Moges R, et al. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression. J Steroid Biochem Mol Biol. 2019;189:161-70.
Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med. 2019;8(1):86-101.
Lohmann AE, Goodwin PJ. Obesity and Breast Cancer: Expanding the Hypothesis Space. JNCI J Natl Cancer Inst. 2021;113(2):107-8.
Lee CL, Tsai CH, Yeh DC, Lin CS, Li YF, Tzeng HE. Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer. Oncotarget. 2017;8(1):1569-79.
Paitan V, Alcarraz C, Leonardo A, Valencia G, Mantilla R, Morante Z, et al. Anemia como factor pronóstico en pacientes con cáncer. Rev Peru Med Exp Salud Pública. 2018;35(2):250.
Chen B, Dai D, Tang H, Ai X, Chen X, Zhang X, et al. Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer. Ahmad A, editor. PLoS One. 2016;11(11):e0165133.
Natalucci V, Virgili E, Calcagnoli F, Valli G, Agostini D, Zeppa SD, et al. Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions. Nutrients. 2021;13(2):482.
Kenar G, Köksoy EB, Ürün Y, Utkan G. Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer. Support Care Cancer. 2020;28(11):5235-42.
Maccio A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, et al. The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica. 2015;100(1):124-32.
Abiri B, Vafa M. Iron Deficiency and Anemia in Cancer Patients: The Role of Iron Treatment in Anemic Cancer Patients. Nutr Cancer. 2020;72(5):864-72.
Abdel-Razeq H, Hashem H. Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia. Crit Rev Oncol Hematol. 2020;145:102837.
Danzinger S, Fügerl A, Pfeifer C, Bernathova M, Tendl-Schulz K, Seifert M. Anemia and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer Invest. 2021;39(6-7):457-65.
Lee K, Kruper L. Dieli-Conwright CM, Mortimer JE. The Impact of Obesity on Breast Cancer Diagnosis and Treatment. Curr Oncol Rep. 2019;21(5): 1-6.
Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S. The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives. Semin Cancer Biol. 2020;60:274-84.
Shamah-Levy T, Mejía-Rodríguez F, Méndez Gómez-Humarán I, De la Cruz-Góngora V, Mundo-Rosas V, Villalpando-Hernández S. Tendencia en la prevalencia de anemia entre mujeres mexicanas en edad reproductiva 2006-2016. Ensanut MC 2016. Salud Pública México. 2018;60(3):301-8.
Mejía-Rodríguez F, Mundo-Rosas V, Rodríguez-Ramírez S, Hernández-F M, García-Guerra A, Rangel-Baltazar E, et al. Alta prevalencia de anemia en mujeres mexicanas en pobreza, Ensanut 100k. Salud Pública México. 2019;61(6, nov-dic):841-51.
Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia: Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014;89(2):203-12.
González-Domínguez Á, Visiedo-García FM, Domínguez-Riscart J, González-Domínguez R, Mateos RM, Lechuga-Sancho AM. Iron Metabolism in Obesity and Metabolic Syndrome. Int J Mol Sci. 2020;21(15):1-27.
Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1): 40-50.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.